We are live on
!
Find out more
US Bancorp Portfolio holdings
AUM
$82.4B
1-Year Est. Return
19.69%
This Fund
S&P 500
This Quarter
Est. Return
+8.01%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$39.1B
AUM Growth
+$2.42B
(+6.6%)
Cap. Flow
-$248M
Cap. Flow
% of AUM
-0.63%
Top 10 Holdings %
Top 10 Hldgs %
22.64%
Holding
3,845
New
218
Increased
1,110
Reduced
1,483
Closed
148
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell Mid-Cap ETF
IWR
|
+$45.6M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$40.7M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$38.8M |
| 4 |
iShares S&P 500 Value ETF
IVE
|
+$35.5M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$34.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$80.2M |
| 2 |
Copart
CPRT
|
+$55.9M |
| 3 |
US Bancorp
USB
|
+$47.8M |
| 4 |
IBDK
iShares iBonds Dec 2019 Term Corporate ETF
IBDK
|
+$25.8M |
| 5 |
iShares Floating Rate Bond ETF
FLOT
|
+$17.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.27% |
| 2 | Financials | 10.78% |
| 3 | Industrials | 9.91% |
| 4 | Healthcare | 9.19% |
| 5 | Consumer Staples | 6.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Armstrong World Industries
AWI
$7B
| $115K | ﹤0.01% |
1,220
+1,098
| +900% | +$105K |
|
2102
Boot Barn
BOOT
$4.7B
| $115K | ﹤0.01% |
+2,600
| New | +$103K |
|
|
BPMC
2103
DELISTED
Blueprint Medicines
BPMC
| $115K | ﹤0.01% |
1,430
+475
| +50% | +$35.6K |
|
2104
Columbus McKinnon
CMCO
$464M
| $115K | ﹤0.01% |
2,856
-1,351
| -32% | -$52.2K |
|
|
EFR
2105
Eaton Vance Senior Floating-Rate Fund
EFR
$313M
| $115K | ﹤0.01% |
8,500
+7,000
| +467% | +$91.3K |
|
2106
Gold Fields
GFI
$29.1B
| $115K | ﹤0.01% |
17,447
+1,823
| +12% | +$10.3K |
|
2107
Cohen & Steers Duration Preferred & Income Fund
LDP
$600M
| $115K | ﹤0.01% |
4,384
+3,532
| +415% | +$91.8K |
|
2108
Teva Pharmaceuticals
TEVA
$36.2B
| $115K | ﹤0.01% |
11,758
-2,687
| -19% | -$24K |
|
2109
Univest Financial
UVSP
$1.23B
| $115K | ﹤0.01% |
4,291
-153
| -3% | -$3.96K |
|
|
CSOD
2110
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $115K | ﹤0.01% |
1,971
+266
| +16% | +$15.4K |
|
2111
Twilio
TWLO
$29.4B
| $114K | ﹤0.01% |
1,161
-83
| -7% | -$8.48K |
|
2112
Veracyte
VCYT
$4.52B
| $114K | ﹤0.01% |
4,103
-40
| -1% | -$1.03K |
|
2113
State Street SPDR S&P Health Care Equipment ETF
XHE
$157M
| $114K | ﹤0.01% |
1,327
| – | – |
|
|
ACRE
2114
Ares Commercial Real Estate
ACRE
$256M
| $113K | ﹤0.01% |
7,111
| – | – |
|
2115
Foster
FSTR
$443M
| $113K | ﹤0.01% |
5,791
-18,619
| -76% | -$362K |
|
2116
Nutanix
NTNX
$15.4B
| $113K | ﹤0.01% |
3,658
-2,924
| -44% | -$86.3K |
|
2117
iShares High Yield Systematic Bond ETF
HYDB
$1.61B
| $112K | ﹤0.01% |
2,208
+180
| +9% | +$9.07K |
|
|
MDCO
2118
DELISTED
Medicines Co
MDCO
| $112K | ﹤0.01% |
1,313
+163
| +14% | +$10.9K |
|
2119
BGC Group
BGC
$5.58B
| $111K | ﹤0.01% |
18,792
+4,180
| +29% | +$23.6K |
|
2120
First Trust Dorsey Wright Focus 5 ETF
FV
$3.62B
| $111K | ﹤0.01% |
3,504
| – | – |
|
2121
iShares Core 1-5 Year USD Bond ETF
ISTB
$5.1B
| $111K | ﹤0.01% |
2,204
+101
| +5% | +$5.09K |
|
|
OPLN
2122
Openlane
OPLN
$4.23B
| $111K | ﹤0.01% |
5,086
-2,533
| -33% | -$57.8K |
|
|
MFA
2123
MFA Financial
MFA
$933M
| $111K | ﹤0.01% |
3,644
| – | – |
|
2124
Powell Industries
POWL
$7.98B
| $111K | ﹤0.01% |
6,822
-24,174
| -78% | -$339K |
|
2125
Seaboard Corp
SEB
$4.48B
| $111K | ﹤0.01% |
26
-1
| -4% | -$4.18K |
|
Similar funds
US Bancorp's Q4 2019 Portfolio in Review
As of Q4 2019, US Bancorp held 3,845 positions worth $39.1B, up 6.6% from $36.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
US Bancorp's Q4 2019 filing shows 218 new, 1,110 increased, 1,483 reduced and 148 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M. The largest sale was Celgene Corp, an estimated $80.2M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.
- US Bancorp's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M.
- US Bancorp added most to iShares Russell Mid-Cap ETF in Q4 2019, an estimated $45.6M increase.
- US Bancorp's biggest Q4 2019 reduction was Copart, cutting an estimated $55.9M.
- US Bancorp fully exited Celgene Corp in Q4 2019, selling an estimated $80.2M.
- US Bancorp's ten largest holdings make up 23% of its $39.1B portfolio in Q4 2019.
- US Bancorp opened 218 new positions and closed 148 in Q4 2019.
- US Bancorp's portfolio value rose 6.6% quarter-over-quarter to $39.1B.
Based on US Bancorp's 13F filing for Q4 2019, filed 4 Feb 2020.